Researchers find possible drug target for PTSD

CHICAGO Mon Sep 5, 2011 4:08pm EDT

Related Topics

CHICAGO (Reuters) - People with post-traumatic stress disorder appear to have lower levels of a specific kind of brain chemical known as serotonin 1B, and targeting this with drugs could lead to the first treatments specifically targeting the disorder, researchers said on Monday.

Currently, doctors use antidepressants and anti-anxiety drugs to treat PTSD, but these are largely ineffective and were never specifically developed to treat the disorder, in which trauma victims suffer from recurrent memories of trauma, intense guilt or worry, angry outbursts and bad dreams.

"The medications we have these days are not working for PTSD," said Dr. Alexander Neumeister of the Mount Sinai School of Medicine, whose study appears in the Archives of General Psychiatry.

To address this, Neumeister and a team at the Yale Positron Emission Tomography Center used imaging to study the specific differences in the brain between people who have PTSD and others who have had traumatic experiences but do not have PTSD.

For the study, researchers performed positron emission tomography or PET scans of 49 PTSD patients whose conditions arose from a variety of traumatic events, including childhood abuse, domestic violence and military service.

Researchers also looked at the brains of 20 trauma victims with no PTSD and 27 healthy adult volunteers.

They found that people with PTSD had changes in the serotonin 1B receptor, a key neurotransmitter that in animal studies appears to be especially sensitive to stress.

The researchers found that levels of serotonin 1B were substantially lower in patients with PTSD than in healthy patients. Levels of this neurotransmitter were also slightly lower in the non-PTSD group who had been exposed to trauma compared with the healthy volunteers.

And the younger a person was when the trauma occurred, the bigger the difference.

"In those individuals who had early trauma in their life, we found the most severe alteration in the serotonin 1B receptor," Neumeister said in a telephone interview.

The findings, which need to be confirmed by bigger studies, offer a first step in developing drugs specifically designed to target brain changes that occur in people with PTSD.

"Currently, the only medical treatment options for the nearly 8 million American adults with PTSD are anti-depressants and anti-anxiety medications, which show little benefit in improving the mental health of these patients," Neumeister said in a statement.

Neumeister said several drug companies, including Eli Lilly and Merck & Co already are exploring drugs that target this receptor, and other drug targets are being looked at as well.

"Hopefully in the near future we will have drugs that will interfere with this receptor," Neumeister said.

(Editing by Cynthia Osterman)

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see
Comments (4)
Xira wrote:
Ship em’ off to war, and when they come back scarred for life, drug em’ up so they don’t cause problems! GO TEAM USA!

Sep 05, 2011 9:38pm EDT  --  Report as abuse
Bob_In_Texas wrote:
This is phenomenal research & conclusions. PTSD does not result from military or wartime service. While true that veterans probably show a greater degree of PTSD, the disorder appears among rape victims, police, fire fighters and even doctors and nurses. Contrary to the writer of this article, this is a sign of hope that veterans will now be able to be helped, as will thousands of others. I wonder how many firefighters and first responders to the 9/11 attacks and aftermath have shown signs of PTSD? At least now researchers have a targeted area to work on instead of guessing and stumbling around like they have been for decades.

Sep 06, 2011 6:56am EDT  --  Report as abuse
bufotenin wrote:
There is not a brain chemical called serotonin 1B. This is a receptor subtype fo the serotonin family of receptors. If you are going to report science, try to get it correct.

Sep 06, 2011 10:04am EDT  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.